RxDoctor Payments Data

Paul King, MD

Adult Reconstructive Orthopaedic Surgery · Annapolis, MDNPI 1518922491

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,085 of the $21,339 with a category attached, or 94.1%. Smith+Nephew accounts for 97.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $12,599 and has fallen 97.7% since, to $289 in 2025.

$21,339in general payments, 2019–2025

Across 27 payments — averaging $790.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$21K
  • Zimmer Biomet$307
  • Johnson & Johnson$168
  • Native Surgical, LLC$46
  • Supreme Orthopedic Systems, LLC$33
  • Heraeus Medical, LLC.$14
$41,309in research payments, 2019–2025

Across 11 payments — averaging $3755.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$41K

What the payments were for

  • Speaking & faculty fees$20,08594%
  • Food & beverage$1,2546%

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew16$20,771
Zimmer Biomet3$307
Johnson & Johnson5$168
Native Surgical, LLC1$46
Supreme Orthopedic Systems, LLC1$33
Heraeus Medical, LLC.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,339 in reported general payments places this provider in the 60th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$664,585
Medicare patients
1,390
Services billed
4,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib13$238
Mupirocin26$178
Amoxicillin41$113
Oxycodone Hcl14$52
Meloxicam19$52

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →